Dr. Joseph Kurt Bivens, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 751 W Legion Rd Ste 300, Brawley, CA 92227 Phone: 209-956-7725 Fax: 760-351-4949 |
Dr. Susan Junghee Hahm, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 751 W Legion Rd, Suite 201, Brawley, CA 92227 Phone: 760-351-0025 Fax: 760-344-6954 |
Mark Whyte, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 608 G St, Suite 2-b, Brawley, CA 92227 Phone: 760-344-3446 |
Norman E Baron, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 751 W. Legion Road, Suite 300, Brawley, CA 92227 Phone: 760-351-4848 Fax: 760-351-4849 |
Dr. Maria Theresa Dela Cruz Ramones, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 751 W Legion Rd Ste 305, Brawley, CA 92227 Phone: 760-351-3444 Fax: 760-351-3450 |
News Archive
Researchers at the University of California, San Diego School of Medicine say that losing the ability to make a particular kind of sugar molecule boosted disease protection in early hominids, and may have directed the evolutionary emergence of our ancestors, the genus Homo.
Senate Democrats say they cannot accept the provisions in House GOP's newest bill to fund the government. Without agreement between Senate and House, the government could shut down Tuesday.
A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.
Salix Pharmaceuticals, Ltd. has announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.
› Verified 9 days ago